Empagliflozin Eyed for Outpatient Chronic Hyponatremia Empagliflozin Eyed for Outpatient Chronic Hyponatremia

The SGLT2 inhibitor increased sodium and reduced neurocognitive dysfunction in patients with chronic hyponatremia due to the syndrome of inappropriate antidiuresis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news